Canada: Recent Changes In Canadian Intellectual Property Law

Last Updated: September 27 2016
Article by Carmela De Luca

Canada has seen a number of legislative changes in 2014 and 2015 to its Industrial Design Act, the Plant Breeder's Right's Act and the Patent Act. In addition, a Practice Notice related to the Examination of medical diagnostic applications was released by the Canadian Intellectual Property Office (CIPO) in summer 2015, greatly altering the examination procedure and scope of claims that will be allowed by the patent office for diagnostic innovations. A brief synopsis of some of the key changes follows.

Amendments to Canada's Industrial Design Act passed December 2014 have yet to come into force. The amendments introduce changes to registration criteria to bring the Act in line with the Hague Agreement, which allows an applicant to obtain industrial design protection in member states on the basis of a single application. The amendments remove the requirement for originality, introduce a novelty requirement, allow for multiple designs in a single application, and introduce provisions for pre-issue publication. The twelve month grace period is now tied to the priority date and the amendments allow for claiming domestic priority. In addition, the term of protection which is now 10 years from registration, will be the later of 10 years from the registration date or 15 years from the filing date, ensuring that holders receive a minimum of 10 years of protection.

Canada's Plant Breeders' Rights Act (PBRA) was amended to bring the PBRA in line with UPOV, the international plant breeders' regime and came into force on February 27, 2015. The amendments provide for a new grace period allowing a plant variety to be sold in Canada for up to one year prior to the date of application. This grace period exists in addition to the current grace period for sales outside Canada. The term of exclusivity has also been extended from 18 to 25 years for trees, vines, or categories that will be specified by the regulations, or 20 years for all other varieties.

Canada's Patent Act has also seen significant changes introduced which are also not yet in force. Amendments to the Patent Act bring it in line with the Patent Law Treaty. Key changes include the ability to add material contained in a previously filed patent application after the filing date, an opportunity to restore a lost priority right, and unlike the current situation, allow anyone to pay maintenance fees on behalf of an Applicant. Canada's reinstatement provisions were also amended. At present an application that is abandoned can be reinstated as of right if the reinstatement fee and the required action that resulted in abandonment is taken within 12 months of the deadline. The amendments introduce a "due care" standard, although it is unclear at present how the "due care" standard will be applied. Regulations under the amended Patent Act will also introduce a "safe harbour" period and no right of action will exist against a third party acting in good faith that infringes in respect of an abandoned patent.

Although not having the force of law, the Patent Notice to Examiners regarding examination of medical diagnostic methods is having an immediate effect on the scope of patent protection that is being allowed by the Patent Office for diagnostic innovations.

CIPO released a Practice Notice related to the patentability of medical diagnostic applications on June 29, 2015, Examination Practice Respecting Medical Diagnostic Methods – PN 2015-02. The Practice Notice directs Examiners to identify the problem to be solved, guided by the description as well as their understanding of the common general knowledge ("CGK") in the art. The Practice Notice identifies that the problems to be solved in diagnostic methods can be considered as: 1) "data acquisition problems" and 2) "data analysis problems". Methods improving or identifying non-CGK methods (e.g. using a new antibody or non-CGK method for that analyte) for quantitating an analyte may be considered a data acquisition problem, whereas a discovery of an allegedly new correlation between a condition and a known analyte is likely a data analysis problem. If the problem is a data acquisition problem, the solution is provided by the elements that provide a means to acquire data about the analyte. If the problem is a data analysis problem, the solution is provided by the elements relating to the analysis of the acquired data for the purpose of providing diagnostic meaning.

It is clear that data acquisition problem solutions are more likely to be patentable: "[w]here a physical step of data acquisition is identified as an essential element of the construed claim, the claimed subject-matter will likely be statutory". In contrast, "a diagnostic method claim construed as consisting solely of essential elements that are disembodied (e.g. mental processes lacking physicality, no practical application, etc.) will be identified as defective" and not patentable subject matter.

There are several issues with the examination proposed in the Practice Notice. A problem solution approach is not clearly grounded in Canadian law and may be contrary to case-law asserting that claim language should have primacy and components of a claim are presumed to be essential unless the contrary is indicated in the patent. Nonetheless, until judicial pronoucement, it will be advisable to identify any improvements and differences in the method from non-CGK methods and/or to consider any additional steps, combinations of markers or particular reagents that would support arguments that a problem to be solved is a data acquisition problem.

Additional legislative changes are also expected on the horizon to address requirements mandated by other agreements such as the Canada Europe Trans-Atlantic Agreement (CETA) and the Trans Pacific Partnership (TPP). Status updates are available upon request.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Carmela De Luca
Similar Articles
Relevancy Powered by MondaqAI
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions